FDA approves Mylan's biosimilar of Roche's breast cancer treatment

(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar of Roche's blockbuster breast cancer treatment Herceptin.

from Reuters: Health News http://ift.tt/2AjrWsn